Breaking
A Novel Nanotechnology Approach Revolutionizes Chemotherapy Drug Delivery and Efficacy
Monitoring Blood Levels of DNA Fragments Shed by Dying Tumor Cells May Accurately Predict Skin Cancer Recurrence
Groundbreaking Study Reveals Digoxin’s Potential to Halt Cancer Metastasis by Disrupting Tumour Cell Clusters
Unveiling the Immune Secrets of Supercentenarians: How Specialized T-Cells May Drive Exceptional Longevity and Adapt to Age-Related Threats
Large-Scale Veterans Affairs Study Suggests Early Nicotinamide Use Significantly Reduces Skin Cancer Risk
New Hope for Basal Cell Carcinoma Patients: Innovative Viral Therapy Shows Remarkable Tumor Reduction and Immune Activation
Alumis’s Envudeucitinib Fails to Meet Primary Endpoints in Phase 2b Lupus Trial, Shares Plunge Amid Broader TYK2 Inhibitor Challenges
Novartis’s Remibrutinib Emerges as a Differentiated BTK Inhibitor, Evading Liver Safety Concerns Plaguing Rivals in the Autoimmune Landscape
Brazilian Research Identifies Molecular Mechanisms of Early Nerve Invasion in Pancreatic Cancer Offering New Targets for Precision Medicine
Stanford Medicine Pioneers Revolutionary Antibody Therapy, Eliminating Toxic Conditioning for Stem Cell Transplants
2 Sep 2026, Wed

biotech

You Missed

Hematology, Leukemia & Lymphoma

A Novel Nanotechnology Approach Revolutionizes Chemotherapy Drug Delivery and Efficacy

Neuro-Oncology (Brain & CNS)

Monitoring Blood Levels of DNA Fragments Shed by Dying Tumor Cells May Accurately Predict Skin Cancer Recurrence

Breast Cancer: Research & Awareness

Groundbreaking Study Reveals Digoxin’s Potential to Halt Cancer Metastasis by Disrupting Tumour Cell Clusters

Breaking Oncology News & General Research

Unveiling the Immune Secrets of Supercentenarians: How Specialized T-Cells May Drive Exceptional Longevity and Adapt to Age-Related Threats